On 1 October 2021, Dr Tanja Pallmann took over the management of InphA GmbH. She succeeds Dr Konrad Horn as the head of the institute.
Dr Pallmann holds a doctorate in pharmacy and has many years of experience in the pharmaceutical industry. She was responsible for
national and international functions in quality management, quality control and as a qualified person.
Her extensive expertise is an ideal basis to continue the successful path of InphA and to position the Institute for the future.
- InphA’s services
- Consumer protection
01. December 2020On 01 December 1995, the former AMI Arzneimitteluntersuchungsinstitut-Nord GmbH in Emil-Sommer-Straße in Bremen commenced operations. On January 16, 2013, the company was renamed InphA GmbH and the institute underwent a strategic reorientation.>>>
01. September 2020Within the framework of the Global Health Protection Program (GHPP) of the German Federal Ministry of Health, InphA GmbH has been training employees from quality control laboratories of African drug authorities since 2017.>>>
21. August 2017The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) in Bonn and InphA GmbH are cooperating in the training of staff from Quality Control Laboratories from African Drug Supervisory Authorities in the field of drug analysis.>>>